Back to News
Market Impact: 0.3

Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients

Source: Business Wire

Healthcare & BiotechTechnology & Innovation

Jupiter Endovascular reported that publication of a pivotal trial showed its Vertex Thrombectomy System normalized hemodynamics in 50% of pulmonary embolism patients. The brief announcement provides no sample size or additional trial results.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

More News

From AllMind Research

Browse all research